Фексофаст

Quick links

Choose a section

Quick links to important sections

Advertisements

Фексофаст

Selected form

Advertisements
Advertisements

Method of action: Antiallergic

Treatment option: Hives, Rhinitis, Hay Fever

Advertisements

Overview of Фексофаст

Quick Facts

Property Description
Active ingredient Fexofenadine hydrochloride
Form Film-coated tablets, Oral suspension
Pharmacological class Second-generation antihistamine
General purpose Relief of allergic symptoms
Origin Synthetic

Фексофаст: Identity and Pharmacological Classification

Фексофаст is a medicinal product containing the active substance fexofenadine hydrochloride (INN), a compound classified as a synthetic, second-generation antihistamine. Its core identity is defined by its role as a selective peripheral H1-receptor antagonist, targeting the biological mechanism that triggers allergic responses. The compound's origin/type is synthetic, having been developed as an active metabolite.

This classification is critical as it highlights the structural design of fexofenadine, which ensures minimal passage across the blood-brain barrier. This specialized structure differentiates it from older agents, concentrating the therapeutic effect where the allergic reaction occurs.

Composition, Form, and General Purpose

Фексофаст is a single active ingredient product, featuring only fexofenadine hydrochloride, and is typically administered via the oral route. It is available primarily as film-coated tablets or an oral suspension, offering options for adult and pediatric patient groups.

The general purpose of this medication is to provide systemic relief from physical symptoms associated with allergic processes, such as sneezing, itching, and runny nose. The characteristic of being a non-sedating option is a key feature. Fexofenadine is less likely to cause drowsiness than older antihistamines due to its limited ability to cross the blood-brain barrier. This design is intended to provide effective relief while minimizing cognitive disruption. Furthermore, second-generation agents like fexofenadine are utilized for managing seasonal allergies due to their selective, non-sedating profile.

Regulatory References

  1. National Library of Medicine (NIH)
  2. MedlinePlus Drug Information
  3. WHO Essential Medicines List
Advertisements

What side effects are possible with Фексофаст?

Possible Side Effects and Safety Information

Фексофаст (Fexofenadine) is a non-sedating antihistamine. Its established safety profile is documented by regulatory agencies and is generally favorable compared to first-generation antihistamines.

Adverse Reactions

Common adverse reactions, reported by more than 1 in 100 people, primarily involve the central nervous system and gastrointestinal tract, and include headache, drowsiness, dizziness, and nausea. Fatigue is also an identified occasional side effect.

Post-marketing surveillance has identified rare but clinically significant adverse reactions, categorized as frequency "not known" (cannot be estimated from available data). These include serious hypersensitivity reactions such as angioedema (swelling of the face or throat), chest tightness, dyspnoea (difficulty breathing), flushing, and systemic anaphylaxis. Other rare reports encompass palpitations, tachycardia (fast heart rate), insomnia, and sleep disturbances (e.g., paroniria/terrifying dreams).

Safety Restrictions and Precautions

  • Contraindications: The medicine is contraindicated in patients with known hypersensitivity to fexofenadine or its ingredients.
  • Cardiovascular Caution: Caution is advised for individuals with existing cardiovascular disease due to the class-wide association of antihistamines with rare reports of tachycardia and palpitations.
  • Drug/Food Interactions: The absorption of fexofenadine is significantly reduced when taken with antacids containing aluminum or magnesium hydroxide; a two-hour separation is recommended. Absorption is also impaired by fruit juices (grapefruit, apple, orange).
  • Special Populations: Dose adjustment is required for patients with renal impairment due to prolonged drug half-life. Increased exposure is observed in the elderly (65 years and older) and caution is recommended. Use during pregnancy is generally avoided unless clearly necessary (formerly Pregnancy Category C) and is not recommended during breastfeeding, as the drug is excreted into breast milk.
  • Diagnostic Interference: Fexofenadine can suppress the skin's response to histamine, requiring discontinuation for several days before skin allergy testing.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the officially documented information regarding overdose of Фексофаст (Fexofenadine hydrochloride), based strictly on regulatory prescribing information.

Overdose reports have been infrequent and contain limited clinical data. The maximum tolerated dose is not established.

Documented Overdose Manifestations

Regulatory sources indicate that the following specific symptoms have been reported in cases of acute overdose:

  • Drowsiness
  • Dizziness
  • Fatigue
  • Dry mouth

Required Emergency Actions and Management

In the event of a suspected overdose, regulatory guidance mandates specific actions and supportive measures:

  • Immediate Action: Seek emergency medical attention or contact a Poison Control center immediately if an overdose is suspected.
  • Urgent Call: Call emergency services immediately if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.
  • Supportive Care: The standard approach involves providing symptomatic and supportive treatment and considering measures to remove any unabsorbed medicine from the gastrointestinal tract.
  • Antidote/Removal: There is no specific antidote for Fexofenadine overdose. Additionally, haemodialysis is ineffective in removing the substance from the blood.
Advertisements

Therapeutic Uses of Фексофаст

What Фексофаст Treats: Main Uses and Benefits

Фексофаст (Fexofenadine) is applied across therapeutic domains involving symptomatic discomfort driven by allergic responses, contributing to supportive relief and assisting with daily stability. Its clinical indications focus on providing systematic management for common allergic reactions.


Symptomatic Management of Allergic Conditions

The medication is commonly used across conditions characterized by episodic or fluctuating symptom patterns, primarily the disruptive manifestations of Seasonal Allergic Rhinitis (hay fever) and Chronic Idiopathic Urticaria (hives). These conditions represent the primary symptomatic contexts where the medication is applied. It helps address symptom clusters that may become intense or disruptive, including frequent sneezing, profuse runny nose, itchy and watery eyes, and continuous skin itching. A primary benefit includes providing symptomatic relief that helps patients cope more steadily with challenging episodes, especially during peak exposure or chronic flare-ups.

“It is commonly used in conditions that involve a combination of several symptoms, such as the simultaneous experience of a runny nose, sneezing, and itchy eyes.”

This medication is often applied in settings where symptoms become momentarily overwhelming but where the patient requires assistance in symptom stabilization with minimal cognitive disruption. This provides supportive relief when symptoms interfere with routine activities, assisting with the maintenance of alertness and functional capacity for adults, teenagers, and children.

Quick Fact: Relief for Allergic Symptoms
Primary Focus Managing symptoms of Seasonal Allergic Rhinitis (hay fever).
Secondary Focus Easing chronic itching and hives in Chronic Idiopathic Urticaria.
General Benefit Contributes to symptom relief with minimal functional disruption.

Regulatory References

  1. NIH DailyMed drug labeling
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Фексофаст?

Фексофаст, which contains the active ingredient fexofenadine, is generally used to treat symptoms of seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives). Its use is defined by specific indications and contraindications to ensure patient safety and efficacy.


General Usage

Fexofenadine is approved for use in adults and children. The specific age limitations and appropriate dosage vary depending on the country and the formulation (tablet or suspension), but it is often approved for children as young as 6 months of age for certain conditions. Patients should always follow the dosing recommendations provided by a healthcare professional.


Contraindications

Fexofenadine is contraindicated and should not be used by individuals with a known hypersensitivity or allergy to fexofenadine or any other components of the medication.

Caution is advised for certain patient groups, and a healthcare provider should be consulted before use. These groups include:

  • Elderly patients (generally aged 65 and older).
  • Patients with significant kidney impairment (renal insufficiency).
  • Patients with existing or a history of cardiovascular disease, as antihistamines have been associated with heart-related effects in rare cases.

Patients who are pregnant or breastfeeding should also seek medical advice before taking Фексофаст.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fexofast (Fexofenadine) has a specific interaction profile primarily focused on its absorption and transport, as it is minimally metabolized by the hepatic CYP450 enzyme system. Its use requires consideration of several important interactions documented in regulatory information.

Interacting Substance/Class Interaction Effect Implication and Constraint
Antacids (Aluminum & Magnesium) Significantly decreases Fexofenadine absorption. Requires administration separation of approximately two hours to ensure drug effectiveness.
Ketoconazole & Erythromycin Significantly increases Fexofenadine plasma concentrations (AUC and Cmax). This is attributed to the inhibition of drug transport proteins, such as P-glycoprotein (P-gp).
Fruit Juices (e.g., Apple, Grapefruit, Orange) Reduces Fexofenadine bioavailability. Consumption of these juices should be avoided near the time of Fexofenadine administration.

Fexofenadine is a substrate for drug transporters like P-gp and OATP. The interaction profile does not include any official warnings regarding additive sedation or CNS effects with alcohol, and no specific drug combinations are listed as contraindicated solely based on interaction data. The primary official restrictions relate to timing and avoidance to optimize Fexofenadine exposure.

Advertisements

Mechanism of Action

️ Selective Blocking of the Peripheral Histamine H1-Receptor

Фексофаст operates as a selective antagonist that binds to the peripheral Histamine H1-receptor, preventing the binding and subsequent activation of the natural ligand, histamine. This molecular action interrupts the H1 signaling pathway, which is a key physiological process in immediate localized responses.

Modulating Vascular Permeability and Neural Activation

By preventing H1-receptor activation, the mechanism modulates two critical physiological consequences: vascular permeability and sensory nerve excitation. The blockade reduces the histamine-induced increase in fluid extravasation from blood vessels and inhibits histamine-mediated activation of peripheral sensory nerves.

Constraints of Peripheral Activity

The compound's specialized chemical structure results in minimal penetration of the Blood-Brain Barrier (BBB). This constraint restricts the drug's mechanism to H1-receptors in peripheral physiological systems, thereby limiting modulation of central nervous system functions.

Advertisements

Dosage and Administration Information

How to Use Фексофаст: Administration Overview

Фексофаст (fexofenadine hydrochloride) is administered exclusively via the oral route, available primarily as film-coated tablets or an oral suspension. The method of use is structured around specific dosage regimens, frequency, and contextual conditions.

Standard Dosage and Frequency

For adults and children 12 years of age and older, the dosing for symptomatic relief is typically 180 mg once daily (QD) or 60 mg twice daily (BID). The specific frequency pattern (once versus twice daily) depends on the formulation and the indication being addressed. The 180 mg dose is generally considered the maximum adult daily intake across usage contexts.

Contextual Administration Instructions

Adherence to administration timing is necessary for proper systemic uptake. The medicine should be taken with water. The drug must not be taken with fruit juices such as grapefruit, apple, or orange, as these can significantly reduce the amount of medicine absorbed into the body.

Additionally, fexofenadine should be separated from aluminum- or magnesium-containing antacids by approximately 15 minutes to avoid decreased systemic availability.

Population-Specific Adjustments

For adult patients (12 years and older) who have impaired renal function, a dose reduction is indicated. The recommended starting regimen for this specific population is 60 mg once daily. For individuals with impaired liver function, dose adjustment is generally not necessary.

Treatment is typically intended for continuous use throughout the period of symptom presence, such as an entire allergy season or for chronic urticaria, and is not usually administered in fixed cycles.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical Research Findings

Research on this combination is preliminary and primarily documented in small-scale clinical studies. The body of evidence does not yet include large, randomized controlled trials (RCTs).

  • Swellings and Discomfort: Small-scale, non-blinded studies have investigated whether the combination was associated with a reduction in swelling and discomfort, primarily in post-operative and traumatic injury settings.
  • Mobility: Studies evaluated whether the combination was associated with changes in patient mobility and return to activity following trauma.

Tolerability Profile Investigated

Research has focused on the tolerability profile of this compound. Adverse effects reported in the small studies were generally described as mild. The frequency of these events was similar to that observed in patients who received a placebo.

  • Reported Adverse Effects: These included minor digestive discomfort and skin reactions. No serious adverse events were reported in the specific studies examined.

Dosage and Duration Studied

To document the study's parameters, the research monitored participants during a treatment period that typically lasted one to two weeks. The studies utilized a treatment regimen involving three daily administrations of the formulation.

Parameter Studied Description of Study Protocol
Administration Three daily administrations
Duration Typically 1 to 2 weeks

Summary of Initial Findings

Summary: research has focused on the potential effects of the combination. Further research, particularly larger-scale, methodologically rigorous studies, would be needed to clarify any effects.

Key Studies & References National Institute for Health and Care Excellence (NICE) Clinical Guideline on Management of Trauma and Post-Surgical Swelling

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Фексофаст (FAQ)


Q: What kind of allergies does Фексофаст treat besides hay fever?

According to official product information, Фексофаст (fexofenadine) is licensed to help relieve symptoms associated with seasonal allergic rhinitis, commonly known as hay fever. It is also indicated for the treatment of uncomplicated skin manifestations related to chronic idiopathic urticaria, which is persistent hives.


Q: How fast does Фексофаст usually start working?

Regulatory documents indicate that the antihistamine effect of fexofenadine can be observed quickly, sometimes within 60 minutes after a single dose in clinical studies. Symptom relief has been noted in clinical studies shortly after the medicine is absorbed.


Q: How long does the effect of Фексофаст last?

The duration of the drug's antihistamine effect is maintained for at least 12 hours following a dose. This long half-life supports the licensed once- or twice-daily dosing schedules.


Q: What should I do if I experience mild dizziness after taking Фексофаст?

Dizziness is a possible side effect of the medicine. Regulatory information advises that if dizziness occurs, activities like driving or operating machinery should be avoided, and resting until the feeling passes is generally recommended.


Q: Are there any known interactions between Фексофаст and alcohol?

While the official labeling does not include a specific drug-alcohol contraindication for fexofenadine, alcohol itself is known to cause drowsiness. Caution is recommended, as alcohol can increase drowsiness, which may be heightened when taken with this medicine.


Q: Does Фексофаст have any interactions with common over-the-counter pain relievers?

Official information indicates that no clinically significant drug interactions were observed in studies between fexofenadine and common pain relievers such as ibuprofen or acetaminophen.


Q: Can Фексофаст be used to treat a runny nose that is not caused by allergies?

The medication is indicated for treating symptoms resulting from allergic rhinitis (caused by allergies). It is not officially approved or studied for treating a runny nose that is not linked to an allergic reaction.


Q: Why are people with liver problems advised to be cautious with Фексофаст?

Dose adjustment is generally not required for patients with liver problems because the drug is minimally processed by the liver. General caution is often recommended when starting any new medicine if a pre-existing liver condition is present.


Q: If I have seasonal allergies, should I take Фексофаст every day or just on symptomatic days?

Official guidance indicates that treatment is typically intended for continuous use throughout the period when an individual is exposed to the allergen, such as an entire allergy season. This approach is consistent with the goal of managing symptoms throughout the exposure period.


Q: Can Фексофаст be taken with other cold or flu medications?

The primary interaction warnings focus on antacids and certain transport protein inhibitors. It is important to review the active ingredients of any cold or flu medicine to identify potential overlaps or interactions that might affect fexofenadine absorption.


Q: Is the onset of action different between the 120mg and 180mg doses of Фексофаст?

Official clinical trial data indicates that the observed onset of action (symptom relief) is consistent across different doses, with effects seen at 60 minutes following the first dose for both the lower and higher licensed regimens.


Q: Is a headache a normal side effect when taking Фексофаст?

Yes, regulatory data classifies headache as one of the most common adverse reactions reported during clinical trials for fexofenadine. It is considered an expected and frequent side effect for some people.


Q: Are there any serious, but rare, side effects I should be aware of?

Yes, while rare, serious side effects reported in post-marketing surveillance include severe hypersensitivity reactions (like swelling of the face or throat), systemic anaphylaxis, and tachycardia (a fast heart rate).


Q: Is Фексофаст available over-the-counter or does it require a prescription?

In many countries, including the United States, fexofenadine is approved for marketing in both Over-the-Counter (OTC) and prescription formulations.


Q: Is there a generic version of Фексофаст available?

Yes, generic equivalents containing the active ingredient fexofenadine hydrochloride are approved by regulatory bodies in various jurisdictions and are generally available.


Q: Can taking Фексофаст for a long time reduce its effectiveness?

Studies, including skin wheal and flare tests, have been conducted and official information indicates there was no evidence of tolerance—meaning no reduced effectiveness—to the antihistamine effects was observed after 28 days of continuous dosing in skin tests.


Q: Why do some people report feeling dizzy on Фексофаст?

Official product information confirms that dizziness is a common adverse reaction reported in clinical trials. However, the specific biological mechanism (the 'why') for this side effect is not detailed in the drug's official regulatory labeling.


Q: Is Фексофаст an anti-inflammatory drug?

Fexofenadine’s primary classification and mechanism is as a selective peripheral H1-receptor antagonist (an antihistamine). While some research suggests it may have secondary anti-inflammatory effects, it is not officially licensed or marketed as an anti-inflammatory drug.


Q: Does Фексофаст help with blocked or stuffy nose symptoms?

Fexofenadine is licensed to treat common allergic symptoms like sneezing, runny nose, and itching. Clinical study results regarding its effectiveness on stuffy nose symptoms have been mixed.


Q: Is there research on the long-term safety of using Fexofenadine?

Yes, studies have been conducted to assess the long-term safety profile of fexofenadine. These trials typically investigate potential effects on the heart's electrical activity (QTc interval) and general tolerability over periods of several months.


Q: What strength of Фексофаст is typically used for chronic urticaria?

For adults and children 12 years and older with chronic idiopathic urticaria, the usual licensed dose is stated as 180 mg once daily, or 60 mg twice daily.


Q: Can I use Фексофаст for pet allergies?

Fexofenadine is officially indicated for the relief of symptoms caused by seasonal allergic rhinitis. This condition covers allergic reactions to airborne allergens, which would include common indoor allergens like pet dander.


Q: Are there different dosages of Фексофаст available?

Yes, fexofenadine is available in different strengths, including film-coated tablets of 30 mg, 60 mg, and 180 mg, as well as an oral suspension for pediatric use.


Q: What is the purpose of the different inactive ingredients in the Фексофаст tablet?

The inactive ingredients are necessary components that do not have a medicinal effect but help form the final product. They include materials like fillers, coloring agents, and coating materials, which ensure the stability and controlled release of the medicine.


Q: What is the chemical class of medicine that Фексофаст belongs to?

Fexofenadine is the active metabolite of terfenadine and is classified chemically as a piperidine derivative, which is a type of organic compound.


Q: Does Фексофаст contain any ingredients that cause allergic reactions themselves?

The medicine is contraindicated in patients with a known hypersensitivity or allergy to the active ingredient (fexofenadine) or any of the tablet’s other inactive ingredients.


Q: Is Фексофаст considered a habit-forming medicine?

Official regulatory labeling does not list fexofenadine as a controlled substance, nor do regulatory summaries include warnings regarding drug abuse or dependence for this product.

Advertisements

How should Фексофаст be stored and disposed of?

Official Storage and Disposal Requirements

Fexofenadine (Fexofast) must be stored according to requirements defined in regulatory labeling to maintain stability and effectiveness.

Storage Conditions

Requirement Details (Based on Labeling)
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Protect from excessive heat and moisture. Liquid forms must also be protected from freezing and light.
Handling Keep the medicine in its original, closed container. Liquid suspensions must be shaken well before use.
Safety Keep out of the sight and reach of children at all times.

Disposal Rules

Do not use the medicine beyond its stated expiry date. To protect the environment, official guidance advises against disposing of unused or expired Fexofenadine by flushing it down the toilet or placing it in household trash. Instead, ask a pharmacist or healthcare professional about local drug take-back programs or other officially sanctioned disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Фексофаст found in:

A-Z Index: